scispace - formally typeset
R

Ruipeng Lu

Researcher at University of Western Ontario

Publications -  14
Citations -  139

Ruipeng Lu is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Gene & DNA binding site. The author has an hindex of 6, co-authored 12 publications receiving 120 citations.

Papers
More filters
Journal ArticleDOI

Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.

TL;DR: Information theory (IT) is applied to predict and prioritize noncoding variants of uncertain significance in regulatory, coding, and intronic regions based on changes in binding sites in these genes.
Journal ArticleDOI

Discovery and validation of information theory-based transcription factor and cofactor binding site motifs

TL;DR: A novel motif discovery pipeline based on recursive, thresholded entropy minimization distinguishes true binding motifs from noise, quantifies the strengths of individual binding sites based on computed affinity and detects adjacent cofactor binding sites that coordinate with the targets of primary, immunoprecipitated TFs.
Journal ArticleDOI

A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer

TL;DR: A strategy for complete gene sequence analysis followed by a unified framework for interpreting non-coding variants that may affect gene expression is presented and large numbers of variants detected by NGS are distilled to a limited set of variants prioritized as potential deleterious changes.
Journal ArticleDOI

Transcription factor binding site clusters identify target genes with similar tissue-wide expression and buffer against mutations.

TL;DR: Multiple information-dense TFBS clusters in promoters appear to protect promoters from effects of deleterious binding site mutations in a single TFBS that would otherwise alter regulation of these genes.
Posted ContentDOI

A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer

TL;DR: This approach distills large numbers of variants detected by NGS to a limited set of variants prioritized as potential deleterious changes and presents a strategy for complete gene sequence analysis followed by a unified framework for interpreting non-coding variants that may affect gene expression.